AxoGen (NASDAQ: AXGN) reported Q4 EPS of ($0.07), $0.01 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $17 million versus the consensus estimate of $15.94 million.

Guidance:

"Management expects that 2018 revenue will grow at least 40% over 2017 revenue and gross margins will remain above 80%."

For earnings history and earnings-related data on AxoGen (AXGN) click here.